Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

ABU Oral Boards > ED > Flashcards

ED Flashcards

1
Q

Men presenting with ED should undergo:

A

GUIDELINE STATMENT 1

A thorough medical, sexual, and psychosocial hx, a PE, and selective laboratory testing

risk factors include: age, comorbid medical and psych condition, prior sx, medication, fhx of vascular dz, personal hx vascular dz, substance abuse, tobacco, neuro dz, endocrinopathies, meds, psychosocial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is recommended to quantify and qualify a man’s sxs with ED?

A

GUIDELINE STATEMENT 2

validated questionnaire

(bother, satisfaction, relationship impact)

IIEF, SHIM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What health concerns can ED be a warning sign of?

A

GUIDELINE STATEMENT 3

CVD

(endothelial dysfunction and inflammation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What initial lab tests for ED should be performed?

A

GUIDELINE STATEMENT 4

testosterone

2 am values (do not measure during acute illness)

(< 300 ng/DL low)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What instances may warranted specialized testing? What does this testing include?

A

GUIDELINE STATEMENT 5

some men warrant specialized testing may guide treatment

young
have strong fhx CVD
hx of pelvic trauma
failed prior ED tx
strong likelihood of primary psychogenic
concomitant PD
lifelong ED

Tests:
**Nocturnal penile tumescence (shaft gauge during sleep)
**ICI (in office: prostaglandin E1, paparavine, and/or phentolamine)
**Penile duplex US (7-10 Hz transducer, 5-10 minutes after ICI → vascular eval: PSV < 30 → arterial insufficiency, EDV > 5 veno-occlusive dz; RI (EDV/PSV >0.80 → normal)
**Caversonometry (quantify pressure after ICI), selective internal pudendal angiography
**Pudendal arteriography (young men with suspected arterial insufficiency)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

For ED, referral to whom after initial evaluation SHOULD be considered? How will this help?

A

GUIDELINE STATEMENT 6

Mental health professions

to promote treatment adherence, reduce performance anxiety, and integrate tx into sexual relationship

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What should clinicians counsel men with ED about lifestyle?

A

GUIDELINE STATEMENT 7

comorbidities negatively affect ED

lifestyle modifications, including changes in diet, increased physical activity, will improve overall health and improve erectile function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is an FDA approved initial treatment option for ED? What should be discussed?

A

GUIDELINE STATEMENT 8

PDE5i (phosphodiesterase type 5 inhibitor)

inhibit breakdown of cGMP → increase smooth muscle relaxation in corpus cavernosum → increased erection hardness

discuss benefits, risks, efficacy

contraindications: nitrates (hypotension), amyl nitrate (poppers) other interactions: antidepressants, anti-fungal, anti-hypertensives, HIV/AIDS drugs

*patients should be stable on alpha blocker prior to initiating PDE5i (some interaction for hypotension)

  1. PDE5i, particularly sildenafil, tadalafil, and vardenafil, appear to have similar efficacy for general population
  2. Dose-response effects across PDE5i meds are small and non-linear (i.e. doubling dose not double effect)
  3. On- demand dosing vs. daily for tadalafil appears to have same level of efficacy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Most common a/e of PDE5i

A

dyspepsia
headache
flushing
back pain
nasal congestion
myalgia
visual disturbance
dizziness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Detail instruction to maximize efficacy for PDE5i

A

GUIDELINE STATEMENT 9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Dosing of PDE5i should be:

A

GUIDELINE STATEMENT 10

titrated to provide optimal efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Patients who try PDE5i without efficacy, what should be considered?

A

Incorrect usage
black market products
require sexual stimulation
waiting and adequate amount of time
fatty meals (sildenafil and vardenafil, tadalafil is unaffected by food)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How are PDE5i metabolized:

A

cytochrome CYP4A system

*dose reduction may be necessary with CYP450 i (ketoconazole, erythromycin, ritonavir, indinivir, grapefruit juice)

Others may enhance: rifampin, phenobarbital, phenytoin, carbamazepine

**Men with severe hepatic or renal dysfunction (GVR < 30) should be stared on lowest dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do you follow men on PDE5i

A

Recheck at 3 mo for BPH and efficacy/adverse effects

If satisfactory, q 6-12 mo for same

ask for changes in meds (nitrates, addition of alpha blocker, etc)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What should patients be informed about penile rehab after RP or RT?

A

GUIDELINE STATEMENT 11

men who desire preservation o f erectile function after treatment for prostate cancer by radical prostatectomy or radiotherapy should be informed that early use of PDE5i post-treatment may not improve spontaneous, unassisted erectile function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Men with ED and testosterone deficiency should be informed:

A

GUIDELINE STATEMENT 12

that PDE5i may be more effective if combined with testosterone therapy

17
Q

In addition to medication therapy, what manual device should patients be informed of?

A

GUIDELINE STATEMENT 13

Vacuum erection device (VED)

*with vacuum limiter

including r/b and burdens

low cost, high degree of satisfaction

a/e: transient penile petechiae or bruising, discomfort or pain, difficulty with ejaculation, difficulty with device, loss of sensitivity

*caution with AC or bleeding disorders or hx of priapism

18
Q

What intraurethral medication can be utilized?

A

GUIDELINE STATEMENT 14

Alprostadil (MUSE→PGE1)

GUIDELINE STATEMENT 15

an in-office test must be performed

100, 250, 500, 100 ug, 10-30 mins before intercourse

a/e: genital pain, minor urethra trauma, urethral pain/burning, dizziness, hypotension/syncope (rare), painful/prolonged erection (1%)

19
Q

Contraindications to MUSE?

A

structural abnormalities such as urethral stricture, penile angulation/fibrosis, infections (balanitis/urethritis)

*condom must be used during sexual activity with pregnant women

20
Q

Men should be informed of what injection therapy?

A

GUIDELINE STATEMENT 16

intracavernosal injections (ICI)

(alprostadil [FDA approved] urethral burning→ increases cGMP; phentolamine → alpha inhibitor inhibit detumescence; papaverine PDEi → together called Trimix [compounded])

GUIDELINE STATEMENT 17

in-office injection test should be performed

wipe with alcohol, inject dorsal 10:00 and 2:00, hold pressure 2-3 mins
pt to assess and self stimulate in office
can only leave when detumesced

a/e: priapism, pain with injection, penile pain, genital pain, penile fibrosis or plaque, and penile deformities

21
Q

What surgical options should men be informed of?

A

GUIDELINE STATEMENT 18

penile prosthesis implantation

malleable or inflatable

risks: risks of procedure, changes in penile appearance, potential for malfunction/failure, irreversible

a/e: penile edema/hematoma, corpus injury, urethral injury, acute urinary retention, crura injury, infection, erosion, mechanical failure

GUIDELINE STATEMENT 19

patients should be counseled on post-op expectations

(not full rigidity, no effect on libido, pain, penile length, girth, sensation

22
Q

Penile prosthetic surgery should not be performed in presence of:

A

GUIDELINE STATEMENT 20

systemic, cutaneous, or UTI

(for sx vanco or first/second gen cephalosporin + aminoglycoside 1 h prior to sx–only in absence of infection)

23
Q

Name 3 (2 popular) approaches to implanting penile prosthesis and advantages/disadvantages:

A

Key: shave at sx, thorough skin prep, Abx
Aminoglycoside + 1st/2nd Gen Cephalosporin or Vanc

  1. Penoscrotal
    1. Proximal corporotomies, cylinder tubing less palpable
    2. along ventrum of corpora
    3. direct visualization of pump placement
    4. disadvantage: reservoir placed blind through perforation of inguinal canal to place retropubic
  2. Infrapubic
    1. allow direct visualization of reservoir placement
    2. pump can be more challenging, dorsal nerves are more at risk, cylinder tubing is more likely to be palpable
  3. Sub-coronal for malleable
24
Q

Intraoperative complications of penile implant?

A
  1. Urethral perforation: blood at meatus, stop, leave cath 7-10 d
  2. Corporal crossover: when dilating corpora if septum perforated, leave dilator in side cross over into, re-dilate the side cross over originated from
  3. Crus perforation: during proximal dilation, create mesh wind sock to buttress rear tip and secure to tunica, secure rear tip itself to tunica albuginea, close corpora around tunica
25
Q

Post op ST and LT complications of penile implant?

A
  1. Infection (1-3%): early with fever, pain swelling, purulence (usually G+); late with chronic pain or skin fixation, elevated WBC or ESR; MUST REMOVE
  2. Malfunction (15-20% @ 10y): replacement of device or part
  3. Erosion: mc in DMII or lack sensation (paraplegia) or malleable → remove eroded cylinder and replace or leave and utilize one cylinder
  4. SST (poor glans support): insufficient distal dilation, small cylinders; remove and re-dilate, but can do glans plication to penile shaft also
  5. Buckling or S-shaped deformities: oversized cylinder; replace cylinders
  6. Auto-inflation: activity inflates device: replace device with lockout mechanism
26
Q

For infected IPP, what are options for mgmt?

A

Remove and salvage (washout, abx) replace: success 80%

Remove and delay replacement, can be challenging due to corporal fibrosis, shortened length (6-12 weeks)

27
Q

For young men with ED and focal pelvic/penile arterial occlusion what are parameters considered and what type of intervention can be considered?

A

GUIDELINE STATEMENT 21

without documented generalized vascular dz or veno-occlusive dysfunction → penile arterial reconstruction

GUIDELINE STATEMENT 22

for ED, penile venous surgery is not recommended

28
Q

What treatments are considered investigational for ED?

A

GUIDELINE STATEMENT 23

low-intensity extracorporeal shock wave therapy (ESWT)

GUIDELINE STATEMENT 24

intracavernosal stem cell therapy

GUIDELINE STATEMENT 25

platelet-rich plasma (PRP)

29
Q

Describe the relevant nerves of the penis:

A

Sensory: dorsal nerves via the pudendal nerve

Sympathetic nerves (T10-L2): superior and inferior hypogastric pelvic plexus, cavernous nerves (NE → maintain flaccidity and detumescence)

Parasympathetic nerves (S2-3): pelvic plexus cavernous nerves (release NO → erections)

30
Q

Describe physiology of an erection:

A

Cavernosal artery smooth muscle relaxation

During stimulation → parasympathetic nerves release NO → increase cGMP → relaxes cavernosal smooth muscle

Arterial dilation → increased arterial inflow → expansion of lacunar spaces

Dilation compresses penile venous outflow (sub-tunical venules and emissary veins that transverse tunica albuginea)

Detumescence → release of NE from sympathetics → vasoconstriction → decreased arterial inflow and increased venous outflow

31
Q

Key components of sexual history:

A

Personal: gender identity, sexual orientation, age of partner(s), relationship status, relationship duration, frequency of sexual activity

Sexual dysfunction: severity, onset, rate of decline, nocturnal erections, ability to sustain erection, exacerbating or alleviating factor, previous tx, degree of distress, goal of tx

Social: job, stress level, life changes, health changes associated with timing

32
Q

Evaluations and Lab tests can be considered if concerned about comorbidities affecting ED?

A

BP
Exercise tolerance
CV risk assessment (High risk (uncontrolled HTN, untreated, uncontrolled conditions, severe CHF) → cardio clearance
Lipid profile
fasting glucose or HbA1c
testosterone (guideline recommended)
CBC (anemia)
BMP (renal failure)
Optional: tailored to patients complaints/risks
TSH
Prl
PSA

33
Q

3 classifications of ED?

A

Organic: vasculogenic (arterial or veno-occlusive), neurogenic, endocrinologic, meds
Psychogenic
Mixed

34
Q

Good questions to ask when initially evaluated patient with ED complaints:

A

Does he ejaculate, if so, pain or blood?

How man sexual partners, STDs?

Morning erections, nocturnal erections, masturbation, spontaneous?

Libido?

How long has ED been a problem?

Is he active, job, exercise? How far/fast can he walk, leg cramp?

How much of problem for him and partner?

35
Q

Important physical exam elements?

A

Gross neuro
General appearance, weight, vitals
Abdomen
External genitalia
DRE
Pulses, extremities

36
Q

Antihypertensive that affect ED? Antihypertensive safe for ED?

A

Adverse: Thiazide, Beta blockers

Safe: Ca antagonists, ACE, ARBs

ABU Oral Boards (36 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions